Sec. 2. Findings
149 words·~1 min read·
/bill/119/s/3076/is/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Congress finds the following: 2-Benzylbenzimidazole opioids are a class of synthetic opioids first synthesized in the 1950s that exhibit significant potency at the mu-opioid receptor, with some substances exceeding the potency of fentanyl. The Drug Enforcement Administration has temporarily or permanently scheduled multiple 2-benzylbenzimidazole opioids compounds under schedule I of section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) ) due to their high abuse potential and lack of accepted medical use.
Nitazenes and related compounds have emerged in the illicit drug supply as designer drugs and contribute to overdose and fatal poisonings in the United States. A class-wide permanent scheduling of 2-benzylbenzimidazole opioids is necessary to preemptively address the proliferation of new analogs, streamline enforcement, and protect public health. The HALT Fentanyl Act ( 28 U.S.C. 801 note; Public Law 119–26 ) created pathways for research using schedule I controlled substances that apply to scheduled nitazenes.
Connectionstraces to 2
Traces to 2 documents
public-private-law
1 reference not yet in our index
- 28 USC 801
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources